Patients
tumour
RECRUITMENT, TUMOUR, SOLID TUMOUR
Recruitment and treatment took place between 23 February 2016 and 20 April 2021. Eligible patients had advanced or metastatic solid tumours not suitable for alternative standard treatment and were over 16 years of age. Immunohistochemical evidence of tumour FRα membrane expression was required (based on a criterion of ≥5% tumour cells with membrane positivity)